Balyasny Asset Management LLC Cv Rx, Inc. Transaction History
Balyasny Asset Management LLC
- $54.8 Billion
- Q1 2024
A detailed history of Balyasny Asset Management LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 618,530 shares of CVRX stock, worth $6.45 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
618,530
Previous 407,008
51.97%
Holding current value
$6.45 Million
Previous $12.8 Million
11.98%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding CVRX
# of Institutions
91Shares Held
13.8MCall Options Held
264KPut Options Held
89.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$42.8 Million15.74% of portfolio
-
Nea Management Company, LLC Timonium, MD2.37MShares$24.7 Million3.03% of portfolio
-
Black Rock Inc. New York, NY765KShares$7.98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA594KShares$6.2 Million0.0% of portfolio
-
Lord, Abbett & Co. LLC Jersey City, NJ589KShares$6.14 Million0.04% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $215M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...